A Prescription From a Clinic That Never Existed: The Six Years of Ruti Aga

The piece of paper was no longer than a hand. It had been torn from an old prescription pad, the pale yellow kind still used in small clinics, and it carried the signature of a relative in Ruti Aga's family. When the Athletics Integrity Unit (AIU) took that paper to the clinic said to have issued it, the answer came back flat: this prescription is not ours. A check of the practitioner registration number followed, and the agency found the signatory had never held a medical licence. Asked about the pad, the person said she had reused an old one from a previous workplace. That workplace confirmed she had never worked there. Three checks, three times the same direction. From that point on, one of the world's leading marathon runners walked into a six-year sanction. Ruti Aga, 32, of Ethiopia. In 2026 she won the Tokyo Marathon, and she has three runner-up finishes at races in the World Marathon Majors system. On the women's road circuit that is enough to place her among the elite of the 2026-2026 window, the group every major podium has to pass through. In March, at a half marathon in China, she won. The sample taken at that race came back positive for methylprednisolone. That substance needs to be stated plainly, because the way it has been reported is distorting the whole story. Methylprednisolone is a synthetic glucocorticoid, a corticosteroid, sitting in class S9 of the WADA list, prohibited in-competition only, and classified as a Specified Substance: a category acknowledged as more plausibly linked to inadvertent or therapeutic use. It is not an anabolic steroid. The distinction is not academic. It sets the baseline sanction and it determines whether a medical explanation can stand. Aga said she used the medication to treat a knee injury. Then she submitted a prescription. On 10 September the AIU published its decision: a six-year ban. The arithmetic is simple, and brutal. Two years for the presence violation. Four years for tampering. Under the WADA Code, when an athlete commits multiple violations the periods are served consecutively, not concurrently. Two plus four makes six. What deserves a pause: the penalty for the paper is double the penalty for the injection. I learned to listen on late-night calls, when athletes say what they will not say in daylight. There was no such call in this case. Nobody sat down with Aga to ask one simple question: before you thought about paperwork, did you apply for a therapeutic use exemption? Picture a different scenario. Had Aga held a valid TUE, or had she honestly declared that she had taken a corticosteroid for her knee before competition, the story would almost certainly have stopped at no violation, or at a far lighter sanction with no aggravating factor. It was the absence of a valid TUE, combined with the fabrication, that pushed the outcome to six years. The AIU verification machinery is no longer as slow as many assume. One call to the clinic. One lookup of a registration number. One cross-check of employment records. Three steps, and a forged document collapses completely. Anyone who still believes fake paperwork is cheaper than hiring a lawyer should reread this case. Sportingly, the consequences are settled. Aga is 32, inside the peak window for women's marathon running, which for women can extend past 35. Six years from 10 September returns her to the start line at roughly 38. In theory, women still race marathons well at that age. But a return to World Marathon Majors podium level after six years without competition is close to a fiction. Attached to that is the damage rarely discussed: the Chinese half marathon result will almost certainly be annulled, meaning the prize money is forfeited. For an East African road runner, races in China are not ceremonial appearances, they are real income built on appearance fees. That revenue stream closes at the same moment as the career. Records are only a shadow; the person is the track. Here the shadow is erased from the results list, while the person has to live with everything after it. The counterintuitive part of this story is how badly it is being read. Most readers will remember it as another Ethiopian doping case. Split it apart, though, and the substance side is the softest part of the file: a class S9 glucocorticoid, in-competition only, a Specified Substance, attached to a knee-injury explanation that is entirely verifiable. The hard part, the part that tripled the sentence, is the paper. And it is the amateurishness that matters most. A real doping operation does not use an old prescription pad from a clinic, does not ask a relative to sign, does not invent a clinic that does not exist as its evidence. The forgery here carries the signature of someone with no adviser, no lawyer who understands the process, no compliance department behind her. It exposes a structural gap in the East African distance-running system: athletes have agents, coaches, contracts, but nobody who knows how to file a TUE. Another reflex needs blocking too: extrapolating to an Ethiopian doping system. This file does not support that. It is a single case, badly handled, inside a talent pipeline deep enough to absorb the absence of one elite athlete almost invisibly. The sanction's effect on the competitive balance of women's marathon is close to nil. Its effect on Aga is everything. Athletics and human life share one thing: everyone has a finish line, but few run the right route. Some athletes never reach the finish, yet keep running in my memory, and Aga has just joined that list with a scrap of paper smaller than a hand. The question I leave behind: if East African athletics could recruit someone who knows how to fill in a form before it recruits someone who runs faster, how many careers would not have had to end at 32?